ZHX3
Basic information
Region (hg38): 20:41178448-41317731
Previous symbols: [ "TIX1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZHX3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 30 | 37 | ||||
missense | 80 | 90 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 4 | |||||
Total | 0 | 0 | 81 | 36 | 14 |
Variants in ZHX3
This is a list of pathogenic ClinVar variants found in the ZHX3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-41185089-G-A | Benign (May 19, 2021) | |||
20-41185209-G-A | Likely benign (Jul 15, 2023) | |||
20-41185212-A-G | Uncertain significance (Feb 16, 2023) | |||
20-41185218-T-C | Likely benign (Sep 03, 2023) | |||
20-41185409-A-AG | Benign (May 19, 2021) | |||
20-41202041-C-G | Likely benign (Jul 03, 2022) | |||
20-41202065-C-T | not specified | Uncertain significance (Aug 09, 2021) | ||
20-41202080-C-A | not specified | Uncertain significance (Jan 23, 2024) | ||
20-41202082-C-T | Likely benign (Sep 21, 2023) | |||
20-41202083-G-C | not specified | Uncertain significance (Dec 20, 2023) | ||
20-41202114-G-A | not specified | Uncertain significance (May 10, 2024) | ||
20-41202147-A-T | Uncertain significance (Apr 20, 2023) | |||
20-41202162-T-C | Uncertain significance (Sep 01, 2022) | |||
20-41202188-G-T | not specified | Uncertain significance (Aug 10, 2024) | ||
20-41202228-T-G | not specified | Uncertain significance (Dec 20, 2023) | ||
20-41202255-C-G | not specified | Uncertain significance (Mar 15, 2024) | ||
20-41202256-C-T | not specified | Uncertain significance (Jan 26, 2022) | ||
20-41202259-T-C | ZHX3-related disorder | Benign (Jan 26, 2024) | ||
20-41202289-G-A | Likely benign (Jan 29, 2024) | |||
20-41202359-T-C | Uncertain significance (Jun 24, 2023) | |||
20-41202378-G-A | not specified | Uncertain significance (Nov 25, 2024) | ||
20-41202380-T-A | not specified | Uncertain significance (Jul 12, 2022) | ||
20-41202381-T-A | not specified | Uncertain significance (Oct 16, 2023) | ||
20-41202391-A-G | Likely benign (Apr 16, 2021) | |||
20-41202394-G-A | Likely benign (May 10, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ZHX3 | protein_coding | protein_coding | ENST00000309060 | 2 | 139225 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0508 | 0.949 | 125733 | 0 | 13 | 125746 | 0.0000517 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.46 | 439 | 534 | 0.823 | 0.0000296 | 6293 |
Missense in Polyphen | 113 | 185.74 | 0.60838 | 2220 | ||
Synonymous | 0.168 | 213 | 216 | 0.985 | 0.0000126 | 1938 |
Loss of Function | 3.61 | 8 | 29.0 | 0.276 | 0.00000164 | 334 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000116 | 0.000116 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000142 | 0.000139 |
European (Non-Finnish) | 0.0000353 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000721 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a transcriptional repressor. Involved in the early stages of mesenchymal stem cell (MSC) osteogenic differentiation. Is a regulator of podocyte gene expression during primary glomerula disease. Binds to promoter DNA. {ECO:0000269|PubMed:12659632, ECO:0000269|PubMed:21174497}.;
Recessive Scores
- pRec
- 0.101
Intolerance Scores
- loftool
- 0.291
- rvis_EVS
- -0.2
- rvis_percentile_EVS
- 39.21
Haploinsufficiency Scores
- pHI
- 0.164
- hipred
- Y
- hipred_score
- 0.670
- ghis
- 0.530
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.875
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Zhx3
- Phenotype
- growth/size/body region phenotype; hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;cell differentiation;positive regulation of osteoblast differentiation;negative regulation of transcription, DNA-templated
- Cellular component
- nucleus;nucleoplasm
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;transcription corepressor activity;protein binding;protein homodimerization activity;metal ion binding;protein heterodimerization activity